Women’s health technology, known as Femtech, is one of the fastest growing and well-funded categories of digital health. Femtech generally encompasses a range of digital health software and tech-enabled service providers that cater to the specific biological needs of women. These needs span from general health and wellness to reproductive health, including fertility, pregnancy, and nursing care. …
Read More
Healthcare Growth Partners is pleased to release our Semi-Annual Health IT Market Review. Our semi-annual report summarizes M&A and private equity activity across health IT, health information services, and digital health. This edition of the report includes an overview of trends seen in 2019 including IPOs, regulatory tailwinds, prolific investor appetite, and a rich cross-section of acquirors.…
Read More
At HGP, we’ve advised and made personal investments in 100+ emerging growth Health IT companies with revenue between ~$5-20 million. We’re often asked about the target…
Read More
Three venture-backed health IT companies completed IPOs in July, ending an almost three-year drought of health IT IPOs. Share prices soared following each IPO, indicative of the enthusiastic response and a desire to see more health IT companies make their way toward public debuts. Composition of revenue, gross margin, and growth are key differentiators between these and all companies and key drivers…
Read More
Healthcare Growth Partners is pleased to release our Semi-Annual Health IT Market Review. Our semi-annual report summarizes M&A and private equity activity across health IT, health information services, and digital health. This edition of the report includes findings from HGP’s analysis of the backlog of venture capital and private equity backed companies which have not yet seen an exit via M&A…
Read More
Even though 2014 was supposed to be the “year of the wearable” according to Forbes, five years later we are now seeing the wearable reach maturity and mass-adoption. This increase in adoption…
Read More
Among the venture capital and growth equity community, a common rule of thumb for software companies is the “Rule of 40”. The rule simply states that a healthy software company’s net profitability + revenue growth rate should exceed 40%. This rule provides a guideline to balance the trade-off between revenue growth and profitability, a question many of our clients frequently have. To see…
Read More
HGP surveyed hundreds of private equity funds across all stages and received 105 responses. Responses concentrated toward Growth Equity and Venture Capital investors, who respectively invest in early and earlier stage companies. The distribution of responses across the stages of investing is consistent with the distribution of investment activity across the company lifecycle. The majority of institutionally…
Read More
Healthcare Growth Partners is pleased to release our Semi-Annual Health IT Market Review. Our semi-annual report summarizes M&A and private equity activity across health IT, health information services, and digital health. This edition of the report includes findings from HGP’s bi-annual Health IT Private Equity Survey, which encompasses feedback from 105 private equity funds with their sentiment…
Read More
There are plenty of “top investor” lists out there – everyone from CB Insights to StartUp Health has compiled a list of the top investors in digital health at some point. We realized these lists are usually…
Read More